RATIONALE: Endocannabinoid-mediated forms of transient synaptic depression have been described in several brain structures, including the dopaminergic ventral tegmental area (VTA). However, their functional and/or behavioural correlates are yet to be determined. OBJECTIVES: The present study was designed to investigate whether back-propagating action potentials in dopamine (DA) neurons, evoked by the stimulation of the medial forebrain bundle (MFB), could trigger endocannabinoid-mediated forms of synaptic modulation. The MFB contains axons ascending from DA neurons to the nucleus accumbens and other forebrain structures, and its stimulation is rewarding because it elicits intra-cranial self-stimulation. MATERIALS AND METHODS: Single cell extracellular recordings were carried out from anti-dromically identified VTA DA neurons in chloral hydrate anesthetized rats. RESULTS: DA neurons responded to MFB stimulation (1 s, 20-80 Hz) with a frequency-dependent increase in spontaneous firing rate, which was enhanced by the cannabinoid type-1 receptor antagonist SR141716A (1 mg/kg) and depressed by the agonist WIN55212-2 (0.125 mg/kg). Increasing brain levels of the endocannabinoid anandamide by blocking its major hydrolysing enzyme, fatty-acid amide hydrolase, with URB597 (0.1 mg/kg) was ineffective, whereas blockade of the endocannabinoid membrane transporter with UCM707 (1 mg/kg) enhanced post-stimulus firing rate. CONCLUSIONS: Our study indicates that stimulation of the MFB evokes an endocannabinoid-mediated short-term modulation of DA neuron activity. Thus, endocannabinoids might play an important role in the mechanisms underlying the rewarding properties of MFB stimulation.
RATIONALE: Endocannabinoid-mediated forms of transient synaptic depression have been described in several brain structures, including the dopaminergic ventral tegmental area (VTA). However, their functional and/or behavioural correlates are yet to be determined. OBJECTIVES: The present study was designed to investigate whether back-propagating action potentials in dopamine (DA) neurons, evoked by the stimulation of the medial forebrain bundle (MFB), could trigger endocannabinoid-mediated forms of synaptic modulation. The MFB contains axons ascending from DA neurons to the nucleus accumbens and other forebrain structures, and its stimulation is rewarding because it elicits intra-cranial self-stimulation. MATERIALS AND METHODS: Single cell extracellular recordings were carried out from anti-dromically identified VTA DA neurons in chloral hydrate anesthetized rats. RESULTS:DA neurons responded to MFB stimulation (1 s, 20-80 Hz) with a frequency-dependent increase in spontaneous firing rate, which was enhanced by the cannabinoid type-1 receptor antagonist SR141716A (1 mg/kg) and depressed by the agonist WIN55212-2 (0.125 mg/kg). Increasing brain levels of the endocannabinoidanandamide by blocking its major hydrolysing enzyme, fatty-acid amide hydrolase, with URB597 (0.1 mg/kg) was ineffective, whereas blockade of the endocannabinoid membrane transporter with UCM707 (1 mg/kg) enhanced post-stimulus firing rate. CONCLUSIONS: Our study indicates that stimulation of the MFB evokes an endocannabinoid-mediated short-term modulation of DA neuron activity. Thus, endocannabinoids might play an important role in the mechanisms underlying the rewarding properties of MFB stimulation.
Authors: Eva de Lago; Stefania Petrosino; Marta Valenti; Enrico Morera; Silvia Ortega-Gutierrez; Javier Fernandez-Ruiz; Vincenzo Di Marzo Journal: Biochem Pharmacol Date: 2005-08-01 Impact factor: 5.858
Authors: Miriam Melis; Simona Perra; Anna Lisa Muntoni; Giuliano Pillolla; Beat Lutz; Giovanni Marsicano; Vincenzo Di Marzo; Gian Luigi Gessa; Marco Pistis Journal: J Neurosci Date: 2004-11-24 Impact factor: 6.167
Authors: Anushka V Goonawardena; John Sesay; Cheryl Ann Sexton; Gernot Riedel; Robert E Hampson Journal: Neuropharmacology Date: 2011-07-13 Impact factor: 5.250
Authors: Theodore Garland; Heidi Schutz; Mark A Chappell; Brooke K Keeney; Thomas H Meek; Lynn E Copes; Wendy Acosta; Clemens Drenowatz; Robert C Maciel; Gertjan van Dijk; Catherine M Kotz; Joey C Eisenmann Journal: J Exp Biol Date: 2011-01-15 Impact factor: 3.312
Authors: Maria Scherma; Zuzana Justinová; Claudio Zanettini; Leigh V Panlilio; Paola Mascia; Paola Fadda; Walter Fratta; Alexandros Makriyannis; Subramanian K Vadivel; Islam Gamaleddin; Bernard Le Foll; Steven R Goldberg Journal: Br J Pharmacol Date: 2012-04 Impact factor: 8.739
Authors: Lauren M Reynolds; Elif Engin; Gabriella Tantillo; Hew Mun Lau; John W Muschamp; William A Carlezon; Uwe Rudolph Journal: Neuropsychopharmacology Date: 2012-07-04 Impact factor: 7.853